Legally Reviewed by Joseph P. Williams on June 9, 2026
Pleural effusion — commonly called “water on the lungs” — is a buildup of excess fluid between the two layers of the pleura, the thin membranes surrounding the lungs. In people with mesothelioma, pleural effusion is not a rare complication: up to 90 percent of pleural mesothelioma patients experience it, and it is frequently the first symptom that sends someone to the doctor. Understanding what pleural effusion means, how it is diagnosed, and how it is treated can help patients and families navigate what often becomes a turning point in a mesothelioma diagnosis.
At The Williams Law Firm, P.C., Attorney Joseph P. Williams has represented mesothelioma patients for over 30 years and has never lost a mesothelioma case. If you or a family member has been diagnosed with pleural mesothelioma or another asbestos-related disease, contact us for a free consultation.
The pleural cavity is the narrow space between the visceral pleura, which wraps around the surface of the lungs, and the parietal pleura, which lines the inside of the chest wall. Under normal conditions this space contains approximately 5 to 15 milliliters of fluid — just enough to allow the lung surfaces to glide smoothly against the chest wall during breathing. Pleural effusion occurs when this fluid accumulates far beyond the normal amount, sometimes reaching several liters.
There are two broad categories of pleural effusion based on how the fluid forms. Transudative effusions occur when hydrostatic or oncotic pressure imbalances force fluid out of blood vessels — common causes include congestive heart failure, liver disease, and kidney disease. Exudative effusions occur when inflammation, infection, or malignancy causes the pleural lining to leak protein-rich fluid — the type most commonly associated with mesothelioma. Malignant pleural effusion (MPE) specifically refers to fluid that contains cancer cells and is a defining feature of advanced pleural mesothelioma.
Mesothelioma is the most serious cause of malignant pleural effusion. When asbestos fibers become lodged in the pleural lining, the chronic inflammation they cause disrupts the normal fluid balance. As mesothelioma tumors grow in the pleural space, they obstruct lymphatic drainage and stimulate fluid production, leading to progressive accumulation. In many patients, this fluid buildup is the symptom that finally triggers medical evaluation — often decades after the original asbestos exposure.
Fluid drained from the pleural space during a diagnostic thoracentesis procedure can be analyzed for the presence of malignant mesothelial cells, making pleural effusion not only a symptom of mesothelioma but also part of the diagnostic pathway. According to the National Cancer Institute, asbestos is a confirmed human carcinogen — the primary cause of mesothelioma and a significant contributor to the malignant pleural effusion that accompanies it.
The symptoms of pleural effusion are caused by the physical pressure the accumulated fluid exerts on the lung and surrounding structures. Common symptoms include progressive shortness of breath that worsens with exertion, a dry or persistent cough, localized chest pain or tightness (often on one side), difficulty lying flat, fever in cases where infection is the underlying cause, unexplained weight loss, and persistent hiccups. In mesothelioma patients, the chest pain may be dull and constant, reflecting tumor involvement of the pleural lining rather than the fluid alone.
Importantly, symptoms often do not appear until a significant amount of fluid has accumulated — sometimes a liter or more. This is one reason mesothelioma is frequently diagnosed at a late stage. If you have a known asbestos exposure history and develop any of these symptoms, inform your physician immediately and specifically mention the asbestos exposure.
The diagnostic process for pleural effusion begins with imaging. A chest X-ray can detect fluid accumulation but cannot identify its source or contents. A CT scan provides more detail on the volume, location, and any associated thickening of the pleural lining or tumor masses. Ultrasound is often used to guide the needle during thoracentesis.
Thoracentesis — also called pleural fluid aspiration — is the definitive diagnostic and initial therapeutic procedure for pleural effusion. Using ultrasound guidance, a physician inserts a needle or thin catheter through the chest wall into the pleural space and drains the accumulated fluid. The drained fluid is analyzed for protein levels, LDH, glucose, cell counts, and the presence of malignant cells through cytology. Finding cancer cells in the pleural fluid confirms malignant pleural effusion and strongly supports a mesothelioma diagnosis.
Thoracentesis also provides immediate symptomatic relief for patients struggling to breathe — fluid removal of 1 to 1.5 liters can dramatically improve breathing within hours. However, in mesothelioma patients, the fluid typically recurs as the underlying cancer continues to stimulate production.
When pleural fluid cytology is insufficient to confirm mesothelioma, a pleural biopsy provides definitive diagnosis. Video-assisted thoracoscopic surgery (VATS) allows direct visualization of the pleural cavity, targeted biopsy of visible tumor tissue, and thorough fluid drainage in a single procedure. Pathologists analyze the tissue sample to confirm mesothelioma and determine the cell type — epithelioid, sarcomatoid, or biphasic — which affects treatment planning and prognosis.
Managing pleural effusion in mesothelioma patients requires both treating the underlying cancer and controlling fluid recurrence. Several procedures are used depending on the patient’s overall health, disease stage, and whether long-term control is the goal.
For patients who are not candidates for more aggressive procedures, repeated thoracentesis can be performed as needed to drain recurrent fluid and maintain comfort. While not a permanent solution, it is minimally invasive and can be performed on an outpatient basis.
Pleurodesis is a procedure that permanently seals the pleural space to prevent fluid from re-accumulating. A chemical irritant — most commonly talc — is introduced into the pleural cavity, triggering inflammation that causes the two pleural layers to fuse together. Once successfully completed, pleurodesis eliminates the space where fluid would otherwise accumulate. It is most effective when the lung is able to fully expand after fluid drainage. Learn more about talc pleurodesis as a treatment for recurring pleural effusion.
An indwelling pleural catheter (IPC) is a tunneled tube placed semi-permanently in the chest that allows patients or caregivers to drain fluid at home on a regular schedule. This approach is particularly useful for mesothelioma patients with trapped lung — a condition where pleural scarring prevents full lung re-expansion and makes pleurodesis less effective. IPCs improve quality of life and reduce hospitalization time in patients with recurrent malignant pleural effusion.
In early-stage mesothelioma patients who are candidates for aggressive surgery, procedures such as extended pleurectomy/decortication (P/D) or extrapleural pneumonectomy (EPP) address both the cancer and the fluid by removing affected pleural tissue. These surgeries offer the best chance of long-term disease control in eligible patients.
The presence of malignant pleural effusion indicates that mesothelioma has reached a stage where the cancer involves the pleural lining broadly enough to disrupt fluid balance. For patients with pleural mesothelioma, effusion is a clinical feature rather than a separate prognostic finding — outcomes depend on the overall stage, cell type, and treatment approach rather than the effusion itself.
What matters for prognosis is early detection and aggressive treatment at a mesothelioma specialist center. Patients with epithelioid cell type diagnosed at stage one or two who are candidates for multimodal treatment, including surgery, chemotherapy, and immunotherapy, can achieve meaningfully better outcomes than the overall median. This is one reason why seeking evaluation at a specialized mesothelioma center immediately after diagnosis — rather than waiting — is so important for understanding your mesothelioma diagnosis and options.
Pleural effusion is frequently the first concrete sign that decades of asbestos exposure has produced mesothelioma. If you or a family member has received this diagnosis, you have legal rights against the companies that manufactured and distributed the asbestos-containing products responsible for the exposure. The statute of limitations for mesothelioma personal injury claims in New York is three years from the date of diagnosis.
Attorney Joseph P. Williams has never lost a mesothelioma case and has recovered hundreds of millions of dollars for patients and families across New York, New Jersey, Texas, and beyond. He handles all cases on a contingency fee basis and will come to your home for the initial consultation. Reach out through our contact form to schedule a free consultation today.
Pleural effusion is extremely common in pleural mesothelioma — up to 90 percent of patients experience it. It is often the first symptom that prompts medical evaluation, and in many patients it develops before other signs of the cancer become apparent. Overall, more than 1.5 million people are diagnosed with a pleural effusion of any cause each year in the United States, making it one of the most common respiratory conditions treated by pulmonologists and thoracic surgeons.
Not necessarily. Pleural effusion has many causes, including congestive heart failure, pneumonia, liver disease, kidney disease, pulmonary embolism, and various cancers. However, if you have a known history of asbestos exposure and develop pleural effusion, mesothelioma must be ruled out through proper diagnostic testing — including fluid analysis by thoracentesis and potentially a pleural biopsy. Inform your physician of your asbestos exposure history, as this significantly changes the differential diagnosis and the urgency of specialist referral.
Pleural effusion is a buildup of fluid in the pleural space between the lung and chest wall. Pleural thickening is the scarring and hardening of the pleural membrane itself, caused by chronic inflammation or tumor invasion. In mesothelioma, both often occur simultaneously — fluid accumulates in the pleural space while the pleural lining itself thickens with tumor growth. Pleural thickening seen on imaging in someone with asbestos exposure history is a serious finding that warrants immediate specialist evaluation.
In mesothelioma patients, the fluid tends to recur because the underlying cancer continues to stimulate its production. Management rather than cure is the typical goal. Repeated thoracentesis drains fluid as needed. Pleurodesis — chemically fusing the pleural layers together — permanently eliminates the space where fluid accumulates and is effective in patients whose lung can fully expand. Indwelling pleural catheters allow ongoing home drainage for patients where pleurodesis is not possible. Treating the mesothelioma itself with surgery, chemotherapy, and immunotherapy is the only approach that can reduce fluid production at its source.
Pleural effusion in the context of mesothelioma develops as part of the cancer itself, which has a latency period of 20 to 60 years after asbestos exposure. This means that workers exposed to asbestos in the 1950s, 1960s, and 1970s may only now be developing symptoms including pleural effusion. The effusion does not develop gradually over those decades — it typically develops as the mesothelioma tumor grows and disrupts normal pleural fluid balance, which happens years or decades after the asbestos fibers first became embedded in the pleura.
As the founding partner of Williams Law Firm, Joseph P. Williams has dedicated over 30 years to representing mesothelioma victims and their families. His firm has recovered hundreds of millions of dollars for those affected by asbestos exposure, offering personalized, aggressive legal advocacy. Based in New York, Williams Law Firm provides free consultations and handles cases nationwide.
